Andamento BAYN.DE · Bayer
Cosa dice MarketSider oggi
Chi è Bayer
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
Valutazione
Redditività
Crescita
Solidità Finanziaria
Dividendi
Cosa ne pensano gli analisti
Approfondisci i fondamentali
Analisi tecnica AI — 01 settembre 2026
RSI (14) — Zona neutrale58▾
MACD — MACD positivo debole0.32▾
Performance oggi — Invariato-0.33%▾
Volume — Volume basso1.7M▾
Sentiment AI notizie — Neutro0▾
Continua a imparare
Titoli correlati — Farmaceutico
18 in evidenza ora (selezione per movimento) · 48 nel settore
Ultime notizie su Bayer
Nessuna notizia recente su Bayer
Le notizie vengono aggiornate ogni 2 ore dalla pipeline AI.
Vai alle ultime notizieAnalisi approfondita su Bayer: target price, rischi, opportunità e confronto competitor.